eburnamenine

{{notability|date=November 2013}}

{{Chembox

| ImageFile = Eburnamenine.svg

| ImageAlt =

| IUPACName = Eburnamenine

| SystematicName = (4¹R,13aR)-13a-Ethyl-2,3,4¹,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 517-30-6

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = LB9CWH9GJ2

| PubChem = 6857502

| ChemSpiderID = 5256838

| ChEBI = 35644

| SMILES = CC[C@]12CCCN3[C@H]1c4c(c5ccccc5n4C=C2)CC3

| StdInChI = 1S/C19H22N2/c1-2-19-9-5-11-20-12-8-15-14-6-3-4-7-16(14)21(13-10-19)17(15)18(19)20/h3-4,6-7,10,13,18H,2,5,8-9,11-12H2,1H3/t18-,19+/m0/s1

| StdInChIKey = VKTOXAGUZWAECL-RBUKOAKNSA-N

}}

|Section2={{Chembox Properties

| C=19 | H=22 | N=2

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Eburnamenine is an anticholinergic alkaloid.{{cite journal|pmid=23720886|year=2013|last1=Naaz|first1=H|last2=Singh|first2=S|last3=Pandey|first3=VP|last4=Singh|first4=P|last5=Dwivedi|first5=UN|title=Anti-cholinergic alkaloids as potential therapeutic agents for Alzheimer's disease: An in silico approach|volume=50|issue=2|pages=120–5|journal=Indian Journal of Biochemistry & Biophysics}}